Ameriprise
HCAT icon

Ameriprise’s Health Catalyst HCAT Stock Holding History

Ameriprise’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-67,607
Closed -$478K – 4078
2024
Q4 		$478K Sell
67,607
-76,531
-53% -$610K ﹤0.01% 3539
2024
Q3 		$1.17M Sell
144,138
-167,522
-54% -$1.21M ﹤0.01% 3153
2024
Q2 		$1.99M Sell
311,660
-113,495
-27% -$729K ﹤0.01% 2867
2024
Q1 		$3.2M Sell
425,155
-19,574
-4% -$179K ﹤0.01% 2633
2023
Q4 		$4.12M Sell
444,729
-49,111
-10% -$401K ﹤0.01% 2492
2023
Q3 		$5M Buy
493,840
+144,938
+42% +$1.73M ﹤0.01% 2297
2023
Q2 		$4.36M Sell
348,902
-7,510
-2% -$89.4K ﹤0.01% 2447
2023
Q1 		$4.16M Buy
356,412
+80,173
+29% +$1.02M ﹤0.01% 2441
2022
Q4 		$2.94M Sell
276,239
-25,081
-8% -$242K ﹤0.01% 2620
2022
Q3 		$2.92M Buy
301,320
+195,066
+184% +$2.58M ﹤0.01% 2584
2022
Q2 		$1.54M Buy
+106,254
New +$1.81M ﹤0.01% 2923
2020
Q3 		– Sell
-70,314
Closed -$2.05M – 3752
2020
Q2 		$2.05M Buy
70,314
+38,285
+120% +$1.06M ﹤0.01% 2591
2020
Q1 		$837K Buy
32,029
+8,915
+39% +$272K ﹤0.01% 2900
2019
Q4 		$802K Buy
23,114
+1,505
+7% +$49.8K ﹤0.01% 3154
2019
Q3 		$684K Buy
+21,609
New +$851K ﹤0.01% 3177

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise's HCAT Position: Q1 2025 in Review

Ameriprise sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 67,607 shares — an estimated $478K sold.

Ameriprise first reported a position in HCAT in Q3 2019 and held it in 15 quarters. The position peaked at $5M in Q3 2023. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Ameriprise reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Ameriprise sold 67,607 Health Catalyst shares in Q1 2025, an estimated $478K.
  • Ameriprise first reported a position in Health Catalyst in Q3 2019 and held it in 15 quarters.
  • Ameriprise's Health Catalyst position peaked at $5M in Q3 2023.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.